CUE BIOPHARMA INC. - COMMON STOCK

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

04 окт 2024 09:00:00 Источник Nasdaq GlobeNewswire

Cue Biopharma Announces Pricing of $12.0 Million Public Offering

26 сен 2024 23:26:30 Источник Nasdaq GlobeNewswire

Cue Biopharma Announces Proposed Public Offering

26 сен 2024 23:10:15 Источник Nasdaq GlobeNewswire

Cue Biopharma Announces Proposed Public Offering

26 сен 2024 16:27:02 Источник Nasdaq GlobeNewswire

Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer

09 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire

Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference

03 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire

Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights

19 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

13 авг 2024 08:00:01 Источник Nasdaq GlobeNewswire

Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements

25 июл 2024 16:05:00 Источник Nasdaq GlobeNewswire

Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting

04 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire

Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024

03 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire

Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

09 май 2024 16:05:01 Источник Nasdaq GlobeNewswire

Cue Biopharma to Present at the 20th Annual PEGS Boston Summit

08 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference

07 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

24 апр 2024 10:01:00 Источник Nasdaq GlobeNewswire

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights

08 апр 2024 16:05:00 Источник Nasdaq GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

02 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

29 фев 2024 10:00:00 Источник Nasdaq GlobeNewswire

Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

06 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire

Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit

22 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire